CHEK1 and neoplasm: Paired pre- and post-treatment blood and fat pad biopsies to assess histone acetylation, as well as paired tumor biopsies to evaluate checkpoint kinase 1 (CHK1) expression as a pharmacodynamic biomarker, were obtained.